{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:29:05Z","timestamp":1768318145857,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1023\/a:1007534600034","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T05:04:10Z","timestamp":1040533450000},"page":"225-229","source":"Crossref","is-referenced-by-count":5,"title":["Low seroprevalence of HTLV-I and HTLV-II in patients with a sexually transmitted disease"],"prefix":"10.1007","volume":"15","author":[{"given":"B.","family":"Suligoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ciuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Study Group for HTLV and STDs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"201849_CR1","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Sci USA 1980; 77: 7415\u20137419.","journal-title":"Proc Natl Sci USA"},{"key":"201849_CR2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.2910300302","volume":"30","author":"WA Blattner","year":"1982","unstructured":"Blattner WA, Kalyanaraman VS, Robert-Guroff M, et al. The human type-C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T cell leukemia\/lymphoma. Int J Cancer 1982; 30: 257\u2013264.","journal-title":"Int J Cancer"},{"key":"201849_CR3","first-page":"333","volume-title":"Human retrovirology","author":"G de Th\u00e8","year":"1990","unstructured":"de Th\u00e8 G, Gout O, Gessain A, and Lyon-Caen O. HTLV-I associated myelopathies in Western Europe and tropical Africa: Clinical, epidemiological, and immunovirological observations. In: Blattner WA (ed), Human retrovirology. New York: Raven Press, 1990: 333\u2013347."},{"key":"201849_CR4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calendar A, de Th\u00e9 G. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407\u2013410.","journal-title":"Lancet"},{"key":"201849_CR5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0140-6736(92)90797-7","volume":"339","author":"B Hjelle","year":"1992","unstructured":"Hjelle B, Appenzeller O, Mills R, Alexander S, Torre-Martinez N, Jahnker R, Ross G. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992; 339: 645\u2013646.","journal-title":"Lancet"},{"key":"201849_CR6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1537-2995.1990.30991048781.x","volume":"30","author":"M Canavaggio","year":"1990","unstructured":"Canavaggio M, Leckie G, Allain JP, Steaffens JW, Lurian Y, Brettler D, and Lee H. The prevalence of antibody to HTLV-I\/II in United States plasma donors and in United States and French hemophiliacs. Transfusion 1990; 30: 780\u2013782.","journal-title":"Transfusion"},{"key":"201849_CR7","first-page":"167","volume":"59","author":"G de Stasio","year":"1990","unstructured":"de Stasio G, Canavaggio M., Rizzi L, et al. Screening for anti-human T-lymphotropic virus antibody in blood donors and polytransfused patients in Apulia (Italy). Vox Sang 1990; 59: 167\u2013171.","journal-title":"Vox Sang"},{"key":"201849_CR8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.2655084","volume":"244","author":"HH Lee","year":"1989","unstructured":"Lee HH, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989; 244: 471\u2013475.","journal-title":"Science"},{"key":"201849_CR9","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0140-6736(91)93126-T","volume":"i","author":"HH Lee","year":"1991","unstructured":"Lee HH, Swanson P, Rosenblatt JD, et al. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991; i: 1435\u20131439.","journal-title":"Lancet"},{"key":"201849_CR10","first-page":"21","volume":"34","author":"JM Lemaire","year":"1991","unstructured":"Lemaire JM, Coste J, Barin F, Courouc\u00e9 AM. Epidemiologic study of anti-HTLV-I\/II antibodies in blood donors in metropolitan France. The retrovirus working group of the National Blood Transfusion Society. Rev Fr Transf Hemobiol 1991; 34: 21\u201334.","journal-title":"Rev Fr Transf Hemobiol"},{"key":"201849_CR11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-111-7-555","volume":"111","author":"EL Murphy","year":"1989","unstructured":"Murphy EL, Figueroa JP, Gibbs WN, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1989; 111: 555\u2013560.","journal-title":"Ann Intern Med"},{"key":"201849_CR12","first-page":"89","volume":"9","author":"D Vlahov","year":"1995","unstructured":"Vlahov D, Khabbaz RF, Cohn S, Galai N, Taylor E, Kaplan J. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, USA. J Acquir Immune Defic Syndr 1995; 9: 89\u201396.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"201849_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00042560-199606010-00014","volume":"12","author":"JE Kaplan","year":"1996","unstructured":"Kaplan JE, Khabbaz R, Murphy EL, Hermansesn S, et al. Male-to-female transmission of human T-cell lymphotropic virus types I and II: Association with viral load. J Acquir Immune Defic Syndr 1996; 12: 193\u2013201.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"201849_CR14","first-page":"295","volume-title":"Human retrovirology","author":"EL. Murphy","year":"1990","unstructured":"Murphy EL. The epidemiology of HTLV-I: Modes of transmission and their relation to patterns of seroprevalence. In: Blattner WA (ed), Human retrovirology. New York: Raven Press, 1990; 295\u2013305."},{"key":"201849_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJM199202063260604","volume":"326","author":"RF Khabbaz","year":"1992","unstructured":"Khabbaz RF, Onorato IM, Cannon RO, Harley TM, Robert B, Hosein B, Kaplan JE. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326: 375\u2013380.","journal-title":"N Engl J Med"},{"key":"201849_CR16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/infdis\/165.5.920","volume":"165","author":"SZ Wiktor","year":"1992","unstructured":"Wiktor SZ, Cannon RO, Atkinson WL, Lutz B, Hook III EW, Blattner WA, Quinn TC. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. J Inf Dis 1992; 165: 920\u2013924.","journal-title":"J Inf Dis"},{"key":"201849_CR17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00042560-199707010-00007","volume":"15","author":"JP Figueroa","year":"1997","unstructured":"Figueroa JP, Ward E, Morris J, et al. Incidence of HIV and HTLV-I among sexually transmitted disease clinic attenders in Jamaica. J Acquir Immune Defic Syndr 1997; 15: 232\u2013237.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"201849_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/095646249400500203","volume":"5","author":"Suligoi B, Giuliani M, Binkin Nthe STD Surveillance Working Group.","year":"1994","unstructured":"Suligoi B, Giuliani M, Binkin N & the STD Surveillance Working Group. The National STD Surveillance System in Italy: Results of the first year of activity. Intern J STD & AIDS 1994; 5: 93\u2013100.","journal-title":"Intern J STD & AIDS"},{"issue":"6","key":"201849_CR19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/jcm.29.6.1125-1127.1991","volume":"29","author":"TM Hartley","year":"1991","unstructured":"Hartley TM, Malone GE, Khabbaz RF, et al. Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21e antibody detection enzyme immunoassay as a supplementary test in HTLV-I\/II antibody testing algorithms. J Clin Microbiol 1991; 29(6): 1125\u20131127.","journal-title":"J Clin Microbiol"},{"issue":"suppl.8","key":"201849_CR20","first-page":"35S","volume":"32","author":"C Fang","year":"1992","unstructured":"Fang C, Layung LG, Sandler SG, Canavaggio M, Laitila V, Lee H. A dot blot immunoassay for serological confirmation and differentiation of HTLV-I and HTLV-II. Transfusion 1992; 32(suppl. 8): 35S.","journal-title":"Transfusion"},{"key":"201849_CR21","first-page":"281","volume":"65","author":"World Health Organization.","year":"1990","unstructured":"World Health Organization. Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2 and HTLV-I\/HTLV-II. Wkly Epidem Rec 1990; 65: 281\u2013288.","journal-title":"Wkly Epidem Rec"},{"key":"201849_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0928-0197(94)90018-3","volume":"2","author":"HH Lee","year":"1994","unstructured":"Lee HH, Galli C, Burczak JD, et al. A multicentric seroepidemiological survey of HTLV-I\/II in Italy. Clin Diagn Virol 1994; 2: 139\u2013148.","journal-title":"Clin Diagn Virol"},{"key":"201849_CR23","volume-title":"Confidence intervals and statistical guidelines","author":"MJ Gardner","year":"1989","unstructured":"Gardner MJ, Altman DG. Statistics with confidence. Confidence intervals and statistical guidelines. London: British Medical Journal Publishing, 1989."},{"key":"201849_CR24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0277-5379(88)90267-2","volume":"24","author":"A De Rossi","year":"1988","unstructured":"De Rossi A, Bortolotti F, Cadrobbi P, Chieco-Bianchi L. Trends of HTLV-I and HIV infections in drug addicts. Eur J Cancer Clin Oncol 1988; 24: 279\u2013280.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"201849_CR25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(90)92140-D","volume":"ii","author":"D Zella","year":"1990","unstructured":"Zella D, Morri L, Sala M, et al. HTLV-II infection in Italian drug abusers. Lancet 1990; ii: 575\u2013576.","journal-title":"Lancet"},{"key":"201849_CR26","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/00002030-199009000-00022","volume":"4","author":"G Marinucci","year":"1990","unstructured":"Marinucci G, Di Giacomo C, Dato A, et al. Seropositivity for HTLV-I among Italian prisoners. AIDS 1990; 4: 930\u2013932.","journal-title":"AIDS"},{"key":"201849_CR27","unstructured":"Roman\u00f2 L, Toia C, Tanzi E, et al. Prevalence of HTLV-I and HTLV-II antibodies among Italian injecting drug users. AIDS and related diseases; X anniversary of the Italian National Association against AIDS, 30 November\u20134 December 1995: 86."},{"key":"201849_CR28","first-page":"68","volume":"13","author":"The HTLV European Research Network.","year":"1996","unstructured":"The HTLV European Research Network. Seroepidemiology of the human T-cell leukaemia\/lymphoma viruses in Europe. J Acquir Immune Defic Syndr 1996; 13: 68\u201377.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"201849_CR29","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJM199206253262616","volume":"326","author":"AR Zanetti","year":"1992","unstructured":"Zanetti AR, Galli C. Seroprevalence of HTLV-I and HTLV-II. N Engl J Med 1992; 326: 1783.","journal-title":"N Engl J Med"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007534600034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007534600034\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007534600034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T04:47:12Z","timestamp":1753850832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007534600034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["201849"],"URL":"https:\/\/doi.org\/10.1023\/a:1007534600034","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}